Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker ...

The study needs to be expanded, researchers say, but it could be a promising sign that the weight loss drugs are more ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs Ozempic and Wegovy, medications costing the massive government health program ...

Just before leaving office, the Biden administration has announced costly GLP-1 drugs often used for weight loss are among the 15 medications listed in the next round of Medicare price negotiations.